Respiratory & Nasal Care OTC
•12 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (12)
%
| Company | Market Cap | Price |
|---|---|---|
|
OTC respiratory care products are sold through CVS retail channels.
|
$98.55B |
$77.90
-0.33%
|
|
Provides OTC respiratory and nasal care products as part of its consumer health portfolio.
|
$41.10B |
$9.00
-0.22%
|
|
OTC respiratory/nasal care products (e.g., Zyrtec) fall under the respiratory/nasal care category that Kenvue directly offers.
|
$31.52B |
$16.18
-1.49%
|
|
Respiratory and nasal care OTC products contribute to the OTC consumer health exposure.
|
$11.96B |
$14.34
+1.63%
|
|
Walgreens carries respiratory and nasal care OTC products, including cold/allergy items.
|
$10.36B |
$11.98
|
|
Respiratory & nasal care OTC products are a product category Albertsons offers in-store.
|
$9.86B |
$17.12
-1.10%
|
|
Respiratory and nasal care products are part of Perrigo's self-care offerings.
|
$2.92B |
$21.25
-1.67%
|
|
Respiratory & Nasal Care OTC private-label products.
|
$37.68M |
$4.38
-8.68%
|
|
OTC respiratory & nasal care products are part of Gelteq's verticals and delivery capabilities.
|
$10.55M |
$1.30
-2.99%
|
|
Equivir licensed for OTC upper respiratory wellness; aligns with Respiratory Care OTC products.
|
$7.69M |
$0.64
+0.47%
|
|
Healthcare products for the respiratory system (OTC/consumer respiratory care).
|
$2.32M |
$0.01
|
|
Polyrizon develops intranasal hydrogel barrier devices (nasal sprays) for allergy relief and viral protection, fitting the Respiratory & Nasal Care OTC category.
|
$18114 |
$1.12
-8.94%
|
Loading industry metrics...
Loading comparison data...
